Cost Effectiveness Analysis in Scientific Herbal Therapy Compared to Conventional Therapy for Dyspepsia
DOI:
https://doi.org/10.35814/jifi.v21i2.1470Keywords:
Cost-effectiveness analysis, ICER, scientific herbal medicineAbstract
Dyspepsia is a common digestive disorder among global health problems. This study aimed to examine the cost-effectiveness of scientific herbs in the treatment of dyspepsia. This study has used a societal perspective, but the indirect costs are considered equal because the patient is undergoing outpatient care. The analysis was used to determine the cost-effectiveness using the Incremental Cost-Effectiveness Ratio (ICER) method. The results were reported in rupiah currency, which includes categories of direct medical costs and direct non-medical costs. Sensitivity analysis reported changes in results, taking into account various possible influencing variables. A total of 62 patients who were respondents in this study were included in scientific herbal therapy (48.38%) and conventional dyspepsia therapy (51.62%). The cost of scientific herbal therapy was higher than conventional dyspepsia therapy (45.558±4.351 vs. 39.202±4.500). However, this difference was not statistically significant on the effectiveness of therapy (96.67% vs. 90.62%; p-value 0.600), the utility index of scientific herbal medicine was greater than conventional dyspepsia therapy (0.85±0.11 vs. 0.74±0.14). The ICER value for 1 additional unit of effectiveness was IDR 105,933; while for the addition of 1 unit of quality of life was IDR 57,781. The effectiveness of scientific herbal medicine therapy for dyspepsia was greater than the effectiveness of conventional dyspepsia therapy, where the cost was higher but the effectiveness was better.
References
Downloads
Published
Issue
Section
License
Licencing
All articles in Jurnal Ilmu Kefarmasian Indonesia are an open-access article, distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License which permits unrestricted non-commercial used, distribution and reproduction in any medium.
This licence applies to Author(s) and Public Reader means that the users mays :
- SHARE:
copy and redistribute the article in any medium or format - ADAPT:
remix, transform, and build upon the article (eg.: to produce a new research work and, possibly, a new publication) - ALIKE:
If you remix, transform, or build upon the article, you must distribute your contributions under the same license as the original. - NO ADDITIONAL RESTRICTIONS:
You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
It does however mean that when you use it you must:
- ATTRIBUTION: You must give appropriate credit to both the Author(s) and the journal, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
You may not:
- NONCOMMERCIAL: You may not use the article for commercial purposes.
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

















